Etya

Etya is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2345 references associated with Etya in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Etya

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Etya

MeSH term MeSH ID Detail
Blast Crisis D001752 2 associated lipids
Pasteurellosis, Pneumonic D012766 3 associated lipids
Keratitis D007634 7 associated lipids
Arthus Reaction D001183 8 associated lipids
Trichinellosis D014235 9 associated lipids
Hepatoblastoma D018197 10 associated lipids
Airway Obstruction D000402 13 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Drug Eruptions D003875 30 associated lipids
Catalepsy D002375 30 associated lipids
Per page 10 20 | Total 19

NCBI Entrez Crosslinks

All references with Etya

Download all related citations
Per page 10 20 50 100 | Total 602
Authors Title Published Journal PubMed Link
Lerner U Indomethacin inhibits bone resorption and lysosomal enzyme release from bone in organ culture. 1980 Scand. J. Rheumatol. pmid:7455622
Spies C et al. Inhibitory effects of mepacrine and eicosatetraynoic acid on cyclic GMP elevations caused by calcium and hormonal factors in rat ductus deferens. 1980 Naunyn Schmiedebergs Arch. Pharmacol. pmid:6245377
Smolen JE and Weissmann G Effects of indomethacin, 5,8,11,14-eicosatetraynoic acid, and p-bromophenacyl bromide on lysosomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytes. 1980 Biochem. Pharmacol. pmid:6245654
Smolen JE and Weissmann G Lysosomal enzyme release from human granulocytes is inhibited by indomethacin, ETYA, and BPB. 1980 Adv Prostaglandin Thromboxane Res pmid:6246788
Boeynaems JM et al. In vitro effects of arachidonic acid and of inhibitors of its metabolism on the dog thyroid gland. 1980 Prostaglandins pmid:6247748
O'Flaherty JT Involvement of bivalent cations and arachidonic acid in neutrophil aggregation. 1980 Inflammation pmid:6771213
Bryant RW and Bailey JM Isolation of a new lipoxygenase metabolite of arachidonic acid, 8. 11, 12-trihydroxy-5,9,14-eicosatrienoic acid from human platelets. 1979 Prostaglandins pmid:108769
Bokoch GM and Reed PW Inhibition of the neutrophil oxidative response to a chemotactic peptide by inhibitors of arachidonic acid oxygenation. 1979 Biochem. Biophys. Res. Commun. pmid:508315
Sullivan TJ and Parker CW Possible role of arachidonic acid and its metabolites in mediator release from rat mast cells. 1979 J. Immunol. pmid:762430
Kalix P Prostaglandins cause cyclic AMP accumulation in peripheral nerve. 1979 Brain Res. pmid:216462